The sensitivity of neurones in the cingulate cortex of the rat to iontophoretically applied substance P (SP) 
Introduction
The original monoamine hypotheses of the aetiology of depression (Schildkraut, 1965; Coppen, 1967) which were based on pharmacological observations, have led to an almost exclusive association of the action of antidepressant drugs with central neuronal systems which utilize noradrenaline (NA) or 5-hydroxytryptamine (5-HT) as neurotransmitters.
However, this association has never adequately explained either the aetiology of the illness or the means by which drugs can ameliorate it (see Leonard, 1982) . Little consideration has been given to the possible involvement of other central synaptic mediators or modulators in depression or the effects of antidepressant drugs. There are many other substances, both aminergic and non-aminergic, which are suspected of playing a role in central synaptic transmission and there seems to be no particular reason to dismiss a possible involvement of one or more of these substances in mediating the actions of antidepressant drugs.
Of the many peptides which are now listed as putative neurotransmitters in mammalian brain perhaps the most firmly established is the undecapeptide, substance P (SP) (see Porter & O'Connor, 1982) . Recently, Fuxe et al. (1983) speculated that SP may be involved in the mechanism of action of antidepressant drugs. They propose that SP may be a modulator of 5-HT transmission in the CNS and that one of the actions of antidepressant drugs is to change the modulatory interaction between SP and 5-HT. In the present experiments we have investigated a possible involvement of SP in the action of antidepressant drugs by determining the effects of several of these agents on the responsiveness of neurones to SP following their acute and chronic administration. The neuronal population studied was in layers IV-V (approximately) of the anterior cingulate cortex. This region was selected for several reasons: it is easily accessible; we have previously shown that these neurones are strongly excited by SP and also its tD The Macmillan Press Ltd 1984 C-terminal fragments with a similar structure activity profile to other systems (Jones & Olpe, 1982) ; the presence (albeit a sparse presence) of SP-containing terminals has been demonstrated here (Ljungdahl et al., 1978; Inagaki et al., 1982) ; autoradiographic studies show a moderate density of [3H]-SP binding sites in the anterior cingulate cortex (O'Donohue et al., 1983) and finally, in human brain at least, the concentration of SP in the anterior cingulate cortex is more than double that measured in any other cortical region (Crystal & Davies, 1982) . We show here that following the chronic administration of 4 different antidepressant drugs the sensitivity of cingulate cortical units to SP is enhanced but no such effect is seen after a single acute dose. Some of these results have been previously presented in a preliminary form (Jones & Olpe, 1983a,b) .
Methods
All experiments were conducted on male albino rats (RAIf, 300-400 g) anaesthetized with chloral hydrate (400 mg kg-' i.p.). The neurones studied were located between 700 and 1200 jt from the brain pial surface in the anterior cingulate cortex (6-7.5 mm anterior to the interaural line; 0.5-1 mm lateral to the midline with the incisor bar set planar with the ear bars). Conventional techniques were used to record spontaneous action potentials extracellularly and to apply substances by iontophoresis using 3-or 4-barrelled micro-pipettes. The pipettes contained NaCl (4 M) for recording; NaCl (0.165 M) for balancing the iontophoretic currents; SP (0.00 1 M dissolved in 0.165 M NaCl, pH 5-6) and sometimes Lglutamate (0.1 M, pH 6-7). Responses to SP were quantified in the following way: Each response was divided into three 60 s periods; the 60 s period during the application of SP and two consecutive 60 s periods immediately following its termination. The number of spikes which occurred above the pre-SP baseline firing rate was determined in each period (designated Sl, S2 and S3) and this presumably represented the number of spikes produced in response to the peptide application. Comparison of the mean values of Sl, S2 and S3 in drug and control groups was by means of a Student's t test.
Drugs
Substance P (SP, Bachem); L-glutamate sodium salt (Sigma); desipramine HCl (DMI, Ciba-Geigy); chlorimipramine HCl (CMI, Ciba-Geigy); trimipramine methane sulphate (TMI, Servia); zimelidine HCl (ZIM, Astra); diazepam (Hoffman La Roche); fluphenazine HCl (Jannsen). In chronic studies antidepressant drugs were given at 10 mg kg-' (i.p.) and diazepam and fluphenazine at 5 mg kg-1 (i.p.).
Results
These studies were conducted on a total of 704 neurones in 68 rats. There was no significant difference in the baseline firing rate of cingulate cortical neurones from rats 1 day after receiving a course of treatment (7 or 14 days) with any of the drugs tested compared to their corresponding control groups (data not shown). One other possibility which we are considering is that the change in responsiveness to SP arises secondarily to an adaptive change in the cortical monoamine systems. Chronic adniinistration of antidepressant drugs has been shown to elicit adaptive changes in a number of parameters of central monoaminergic function (see Reisine, 1981; Sugrue, 1983 for recent reviews). Since SP-containing terminals as well as NA-and 5-HT-containing terminals exist in the cortex (Beaudet & Descarries, 1978; Ljungdall et al., 1978; Inagaki et al., 1982) it seems quite possible that the amines and peptides could functionally interact at the neuronal level and that a change in the amine system induced by the antidepressant could elicit changes in the responsiveness to the peptide. In the spinal cord, 5-HT has been shown to specifically reduce responses of dorsal horn neurones to SP (Davies & Roberts, 1981) and vice versa (Ward & Roberts, 1983) . We have recently shown that responses to SP in the cingulate cortex can be reduced by both 5-HT or NA applied by iontophoresis, although the effects of the former appear less specific than those of the latter (Jones & Olpe, 1983c) . It has been shown in this laboratory (Olpe & Schellenberg, 1980; Olpe et al., 1981) that, in line with studies showing decreased binding to 1-receptors in the cortex (see Sugrue, 1983) , the sensitivity of cortical cells to the depressant effects of iontophoretically applied NA is reduced by chronic administration of antidepressants. If the NA system is functionally inhibitory on the SP system in the cortex then it is possible that a change in the former could increase responsiveness of the latter. The argument for a similar involvement of 5-HT is less strong since chronic administration of tricyclic antidepressants does not reduce the depressant effects of 5-HT on cortical neurones (Olpe & Schellenberg, 1981) . Fuxe et al. (1983) have recently proposed that a change in the interaction between 5-HT and SP may be involved in the mechanism of action of antidepressants. They have demonstrated that SP can increase the number of 5-HT-binding sites but decrease their affinity in the spinal cord. On this basis they hypothesize a regulatory role for SP on 5-HTmediated transmission. They have speculated that a change in this regulatory interaction may underlie the mechanism of action of antidepressants (Fuxe et al., 1983) . How this relates to the present demonstration of an antidepressant-induced increase in responsiveness to SP is unclear.
Whatever the explanation of the present results it is unlikely that the blockade of monoamine reuptake is involved. The four drugs tested vary widely in their ability to inhibit NA and 5-HT uptake and TMI is virtually inactive on either system (Hyttel, 1983) . It is clear however, that TMI is a clinically effective antidepressant (Settle & Ayd, 1980) as are the other 3 drugs tested and all 4 clearly increase responsiveness to SP, at least in the withdrawal period following their chronic administration. It is not possible to say on the basis of the present experiments whether this indicates a possible involvement of SP in the aetiology of depression or the clinical effect of antidepressants. It would be extremely interesting to determine the concentrations of SP and/or its binding characteristics in post-mortem brain tissue from depressed patients.
Finally, several recently published abstracts have indicated an involvement of other peptides in the action of antidepressant drugs. Thyrotropin releasing hormone is decreased after repeated electroshock treatment but administration of antidepressants results in an elevation of this peptide in some regions of the CNS (Bennett et al., 1983a,b) . Conzelman et al. (1983) have described the ability of several antidepressant drugs to reduce the veratradine-induced release of cholecystokinin from slices of rat striatum. Also, Delbarre et al. (1983) 
